A 1-year-old child is diagnosed with very early onset inflammatory bowel disease (VEO-IBD). The presentation is severe, with extensive colitis and perianal fistulae. Genetic testing identifies a pathogenic variant in the IL10RA gene. What is the most targeted and potentially curative therapy for this specific monogenic disorder?